1,424 Followers on Owler

BioMarin

is a California-based biotechnology company that researches and develops transformative therapies for the treatment of genetic diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

BioMarin

is a California-based biotechnology company that researches and develops transformative therapies for the treatment of genetic diseases... Read more
BioMarin President & CEO: Alexander Hardy

President & CEO

Alexander Hardy

CEO Approval Rating

90/100

1997

PublicNASDAQBMRN

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$3.2B
Employees
3,080
Funding
$1.5B
Acquisitions
9

News

Funding
Jan 26, 2026
PR Newswire
BioMarin received $850M in Post-IPO Debt Funding
Acquisition
Dec 19, 2025
The Wall Street Journal
BioMarin acquired Amicus Therapeutics, Inc. for $4.8B

BioMarin Competitors

1Orchard Therapeutics
2Lexeo
3Regenxbio
4Immusoft
5Sangamo
6Inventiva
7Spark Therapeutics
8Denali Therapeutics
9Esteve
10Roche
Unlock 16 + competitors

Trending Companies